RxDoctor Payments Data

Scott Woller, MD

Internal Medicine · Ft. Harrison, MTNPI 1508966326

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, BD.

$67in general payments, 2019–2025

Across 1 payment — averaging $67.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$67
$767,697in research payments, 2019–2025

Across 9 payments — averaging $85,300 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$450K
  • E.r. Squibb & Sons, L.L.C.$156K
  • BD$140K
  • Grifols Therapeutics LLC$22K

What the payments were for

  • Food & beverage$67100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BD1$67

How this compares

$67 in reported general payments places this provider in the 60th percentile of 244 internal medicine providers in Montana.

See all internal medicine providers in Montana

Medicare billing

Part B allowed, 2024
$28,456
Medicare patients
139
Services billed
343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban291$359,506
XareltoRivaroxaban81$108,668
Enoxaparin Sodium34$11,887

Paid to pharmacies, not to this prescriber.

Other internal medicine in Ft. Harrison

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →